{"entity":{"type":"insider","cik":"0001689819","url":"/insider/0001689819","json_url":"/insider/0001689819.json","name":"Thomas Thomas T.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":19,"n_filings":7,"first":"2018-05-15","last":"2021-09-23","span_basis":"filed_date"},"name_variants":[{"name":"Thomas Thomas T.","source":"filing","n_filings":7,"first_seen":"2018-05-15","last_seen":"2021-09-23"}],"transactions":[{"id":5219381,"accession":"0001385508-21-000138","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001385508-21-000138","line_url":"/filing/0001385508-21-000138#line-5","is_derivative":false,"issuer_cik":"0001385508","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001385508","owner_cik":"0001689819","owner_name":"Thomas Thomas T.","owner_display_name":"Thomas Thomas T.","owner_url":"/insider/0001689819","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":735.0,"shares_display":"735","price_per_share":25.02,"price_display":"25.02","price_state":"stated","total_value":18389.7,"total_display":"18,389.70","total_whole":"18,390","shares_owned_after":10375.0,"shares_owned_after_display":"10,375","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-22","filed_date":"2021-09-23","scope":"insider"},{"id":5219374,"accession":"0001385508-21-000138","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001385508-21-000138","line_url":"/filing/0001385508-21-000138","is_derivative":false,"issuer_cik":"0001385508","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001385508","owner_cik":"0001689819","owner_name":"Thomas Thomas T.","owner_display_name":"Thomas Thomas T.","owner_url":"/insider/0001689819","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":831.0,"shares_display":"831","price_per_share":24.116389891696752,"price_display":"24.12","price_state":"stated","total_value":20040.72,"total_display":"20,040.72","total_whole":"20,041","shares_owned_after":9276.0,"shares_owned_after_display":"9,276","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-21","filed_date":"2021-09-23","scope":"insider","n_lines":2},{"id":4155429,"accession":"0001385508-21-000136","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001385508-21-000136","line_url":"/filing/0001385508-21-000136","is_derivative":false,"issuer_cik":"0001385508","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001385508","owner_cik":"0001689819","owner_name":"Thomas Thomas T.","owner_display_name":"Thomas Thomas T.","owner_url":"/insider/0001689819","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1571.0,"shares_display":"1,571","price_per_share":19.37019096117123,"price_display":"19.37","price_state":"stated","total_value":30430.57,"total_display":"30,430.57","total_whole":"30,431","shares_owned_after":7371.0,"shares_owned_after_display":"7,371","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-14","filed_date":"2021-09-16","scope":"insider","n_lines":3},{"id":4692491,"accession":"0001385508-21-000124","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001385508-21-000124","line_url":"/filing/0001385508-21-000124#line-2","is_derivative":false,"issuer_cik":"0001385508","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001385508","owner_cik":"0001689819","owner_name":"Thomas Thomas T.","owner_display_name":"Thomas Thomas T.","owner_url":"/insider/0001689819","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":822.0,"shares_display":"822","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":14796.0,"total_display":"14,796.00","total_whole":"14,796","shares_owned_after":6653.0,"shares_owned_after_display":"6,653","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-07","filed_date":"2021-09-09","scope":"insider"},{"id":5125207,"accession":"0001385508-21-000116","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001385508-21-000116","line_url":"/filing/0001385508-21-000116","is_derivative":false,"issuer_cik":"0001385508","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001385508","owner_cik":"0001689819","owner_name":"Thomas Thomas T.","owner_display_name":"Thomas Thomas T.","owner_url":"/insider/0001689819","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":16.22,"price_display":"16.22","price_state":"stated","total_value":16220.0,"total_display":"16,220.00","total_whole":"16,220","shares_owned_after":6400.0,"shares_owned_after_display":"6,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-19","filed_date":"2021-08-20","scope":"insider","n_lines":2},{"id":2395753,"accession":"0001385508-20-000096","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001385508-20-000096","line_url":"/filing/0001385508-20-000096#line-2","is_derivative":false,"issuer_cik":"0001385508","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001385508","owner_cik":"0001689819","owner_name":"Thomas Thomas T.","owner_display_name":"Thomas Thomas T.","owner_url":"/insider/0001689819","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":8.05,"price_display":"8.05","price_state":"stated","total_value":4025.0,"total_display":"4,025.00","total_whole":"4,025","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-04","filed_date":"2020-09-08","scope":"insider"},{"id":2395746,"accession":"0001385508-20-000096","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001385508-20-000096","line_url":"/filing/0001385508-20-000096#line-1","is_derivative":false,"issuer_cik":"0001385508","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001385508","owner_cik":"0001689819","owner_name":"Thomas Thomas T.","owner_display_name":"Thomas Thomas T.","owner_url":"/insider/0001689819","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":8.4,"price_display":"8.40","price_state":"stated","total_value":21000.0,"total_display":"21,000.00","total_whole":"21,000","shares_owned_after":4500.0,"shares_owned_after_display":"4,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-03","filed_date":"2020-09-08","scope":"insider"},{"id":6278353,"accession":"0001385508-18-000047","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001385508-18-000047","line_url":"/filing/0001385508-18-000047#line-6","is_derivative":false,"issuer_cik":"0001385508","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001385508","owner_cik":"0001689819","owner_name":"Thomas Thomas T.","owner_display_name":"Thomas Thomas T.","owner_url":"/insider/0001689819","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":16.5,"price_display":"16.50","price_state":"stated","total_value":8250.0,"total_display":"8,250.00","total_whole":"8,250","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-18","filed_date":"2018-05-18","scope":"insider"},{"id":6278347,"accession":"0001385508-18-000047","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001385508-18-000047","line_url":"/filing/0001385508-18-000047","is_derivative":false,"issuer_cik":"0001385508","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001385508","owner_cik":"0001689819","owner_name":"Thomas Thomas T.","owner_display_name":"Thomas Thomas T.","owner_url":"/insider/0001689819","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":16.47,"price_display":"16.47","price_state":"stated","total_value":24705.0,"total_display":"24,705.00","total_whole":"24,705","shares_owned_after":1000.0,"shares_owned_after_display":"1,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-17","filed_date":"2018-05-18","scope":"insider","n_lines":3},{"id":6278340,"accession":"0001385508-18-000047","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001385508-18-000047","line_url":"/filing/0001385508-18-000047","is_derivative":false,"issuer_cik":"0001385508","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001385508","owner_cik":"0001689819","owner_name":"Thomas Thomas T.","owner_display_name":"Thomas Thomas T.","owner_url":"/insider/0001689819","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":763.0,"shares_display":"763","price_per_share":16.32727391874181,"price_display":"16.33","price_state":"stated","total_value":12457.71,"total_display":"12,457.71","total_whole":"12,458","shares_owned_after":2263.0,"shares_owned_after_display":"2,263","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-16","filed_date":"2018-05-18","scope":"insider","n_lines":2},{"id":6702725,"accession":"0001385508-18-000043","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001385508-18-000043","line_url":"/filing/0001385508-18-000043#line-3","is_derivative":false,"issuer_cik":"0001385508","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001385508","owner_cik":"0001689819","owner_name":"Thomas Thomas T.","owner_display_name":"Thomas Thomas T.","owner_url":"/insider/0001689819","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":800.0,"shares_display":"800","price_per_share":17.53,"price_display":"17.53","price_state":"stated","total_value":14024.0,"total_display":"14,024.00","total_whole":"14,024","shares_owned_after":2763.0,"shares_owned_after_display":"2,763","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-15","filed_date":"2018-05-15","scope":"insider"},{"id":6702722,"accession":"0001385508-18-000043","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001385508-18-000043","line_url":"/filing/0001385508-18-000043#line-2","is_derivative":false,"issuer_cik":"0001385508","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001385508","owner_cik":"0001689819","owner_name":"Thomas Thomas T.","owner_display_name":"Thomas Thomas T.","owner_url":"/insider/0001689819","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3500.0,"shares_display":"3,500","price_per_share":18.54,"price_display":"18.54","price_state":"stated","total_value":64890.0,"total_display":"64,890.00","total_whole":"64,890","shares_owned_after":3563.0,"shares_owned_after_display":"3,563","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-14","filed_date":"2018-05-15","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":19,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":17,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":19},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001385508","name":"OPIANT PHARMACEUTICALS, INC.","url":"/issuer/0001385508","role":"Director","n_filings":7,"first_seen":"2018-05-15","last_seen":"2021-09-23"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001689819","retrieved_at":"2026-08-23T21:45:43+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}